Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors
نویسندگان
چکیده
منابع مشابه
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors: Innovative Treatment Therapies for Type 2 Diabetes
the prevalence of diabetes and impaired glucose tolerance is predicted to dramatically increase over the next two decades. clinical therapies for type 2 diabetes mellitus (t2dM) have traditionally included lifestyle modification, oral anti-diabetic agents, and ultimately insulin initiation. In this report, we review the clinical trial results of two innovative t2dM treatment therapies that are ...
متن کاملIncretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes.
The prevalence of diabetes and impaired glucose tolerance is predicted to dramatically increase over the next two decades. Clinical therapies for type 2 diabetes mellitus (T2DM) have traditionally included lifestyle modification, oral anti-diabetic agents, and ultimately insulin initiation. In this report, we review the clinical trial results of two innovative T2DM treatment therapies that are ...
متن کاملAntibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.
BACKGROUND AND OBJECTIVES Hemodialysis patients with type 2 diabetes exhibit an excessive cardiovascular risk and regularly receive heparin. We tested whether antibodies to the platelet factor 4-heparin complex (PF4-H-AB) contribute to outcome. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS In 1255 hemodialysis patients with type 2 diabetes, the German Diabetes Dialysis Study evaluated the eff...
متن کاملEfficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
BACKGROUND Incretin therapy is feasible in patients with type 2 diabetes mellitus undergoing hemodialysis (HD). However, few studies have examined the safety and efficacy of this therapeutic approach in patients with diabetes and renal impairment. Here, we examined glycemic control and the anti-oxidative-stress effects of the dipeptidyl peptidase (DPP)-4 inhibitor linagliptin in patients with t...
متن کاملArterial hypertension management with conversion enzyme inhibitors in hemodialysis patients
By establishing the renal suppletion procedure, the patients with chronic renal failure also have an acceleration of arterial hypertension phenomena. The management of this situation calls for the understanding of the ethological mechanisms (hypervolemia by the reduction of Na excretion and high rennin secretion) and the adaptation of the therapeutic approach to every patient. An individualized...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Diabetes
سال: 2015
ISSN: 1948-9358
DOI: 10.4239/wjd.v6.i6.840